Learn how caffeine affects Parkinson's disease prevention and treatment. New research uncovers both protective benefits and ...
GlobalData on MSN5d
BlueRock accelerates Parkinson’s disease therapy to Phase IIIThe US company has said it is launching the Phase III trials in the first half of this year after Phase I talks with the US ...
Delray Medical Center cut the ribbon on its newest high-tech machine that targets brain areas to treat movement disorders ...
University of Arizona researchers revealed that dyskinesia in Parkinson’s patients stems from a disconnect in the motor ...
A new discovery in blood immune cells has put researchers one step closer to identifying a blood biomarker that would allow ...
A Risky Business: Why Do Some Parkinson's Disease Treatments Affect Decision Making? Sep. 24, 2024 — Parkinson's disease, a debilitating nervous system disorder, is treated with medications that ...
A 47-year-old man was the first in the world to be treated outside of a study context with a new technique for the symptoms of Parkinson's disease in Amsterdam this week, Amsterdam UMC reported. The ...
Treatment with an oral allosteric modulator was nonsuperior to placebo at 6 weeks in adults with Parkinson’s disease whose ...
News Medical on MSN3d
Grifols receives grant for early Parkinson's disease biomarker discoveryGrifols, a global healthcare company and leading producer of plasma-derived medicines, today announced it has received a grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) to ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback